Dana R Sax, MD - Medicare Emergency Medicine in Oakland, CA

Dana R Sax, MD is a medicare enrolled "Emergency Medicine" physician in Oakland, California. She graduated from medical school in 2009 and has 15 years of diverse experience with area of expertise as Emergency Medicine. She is a member of the group practice Permanente Medical Group Inc and her current practice location is 275 W Macarthur Blvd, Oakland, California. You can reach out to her office (for appointments etc.) via phone at (510) 752-1000.

Dana R Sax is licensed to practice in California (license number A125040) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1093941221.

Contact Information

Dana R Sax, MD
275 W Macarthur Blvd,
Oakland, CA 94611-5641
(510) 752-1000
Not Available



Physician's Profile

Full NameDana R Sax
GenderFemale
SpecialityEmergency Medicine
Experience15 Years
Location275 W Macarthur Blvd, Oakland, California
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dana R Sax graduated from medical school in 2009
  NPI Data:
  • NPI Number: 1093941221
  • Provider Enumeration Date: 06/02/2009
  • Last Update Date: 12/15/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 6204092562
  • Enrollment ID: I20140114001166

Medical Identifiers

Medical identifiers for Dana R Sax such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1093941221NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207P00000XEmergency Medicine A125040 (California)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Kaiser Foundation Hospital - Oakland/richmondOakland, CAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Permanente Medical Group Inc89219102257800

News Archive

Derek Muhs selected for Excellence in Branding and Marketing

Health Care Management China today announced that Co-Founder and Vice Chairman Derek Muhs has been nominated for Excellence in Branding and Marketing by the Awards Jury of the 6th Annual CMO ASIA AWARDS, to be held in Singapore on August 11, 2015.

Astex and MMRC commence Phase II clinical trial of AT7519 CDK inhibitor in multiple myeloma

Astex Therapeutics, the UK-based biotechnology company developing targeted therapies for oncology and virology, and the Multiple Myeloma Research Consortium announced today the initiation of a Phase II clinical trial of the cyclin-dependent kinase inhibitor, AT7519, to treat patients with relapsed or refractory multiple myeloma, an incurable blood cancer. The trial is designed to investigate both single agent and combination activity of AT7519 with bortezomib (VelcadeĀ®).

Genetic diversity thwarts the usefulness of malaria vaccine

Researchers at the University of Maryland School of Medicine Center for Vaccine Development (CVD) have charted the extreme genetic differences that occur over time in the most dangerous malaria parasite in the world. While there is no approved vaccine for malaria, various experimental vaccines are in development.

Veeva OpenData services now available in Italy

Today, Veeva Systems announced that it has acquired Merqurio's healthcare professional (HCP) and healthcare organisation (HCO) database for Italy. With the acquisition of this market-leading Italian HCP and stakeholder data, Veeva OpenData now expands to a third major European market and builds on Veeva's commitment to deliver a new approach to customer reference data that is open, easy, and global.

Heilongjiang Tianlong Pharmaceutical changes R&D focus to antibiotics and cardiac drugs

China Sky One Medical, Inc., a leading fully integrated pharmaceutical company developing and producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that Heilongjiang Tianlong Pharmaceutical Company ("Tianlong"), the Company's wholly owned subsidiary, will change its R&D focus from external use medicines to antibiotics and cardiac drugs.

Read more Medical News

› Verified 2 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dana R Sax allows following entities to bill medicare on her behalf.
Entity NamePermanente Medical Group Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1073606299
PECOS PAC ID: 8921910225
Enrollment ID: O20031104000710

News Archive

Derek Muhs selected for Excellence in Branding and Marketing

Health Care Management China today announced that Co-Founder and Vice Chairman Derek Muhs has been nominated for Excellence in Branding and Marketing by the Awards Jury of the 6th Annual CMO ASIA AWARDS, to be held in Singapore on August 11, 2015.

Astex and MMRC commence Phase II clinical trial of AT7519 CDK inhibitor in multiple myeloma

Astex Therapeutics, the UK-based biotechnology company developing targeted therapies for oncology and virology, and the Multiple Myeloma Research Consortium announced today the initiation of a Phase II clinical trial of the cyclin-dependent kinase inhibitor, AT7519, to treat patients with relapsed or refractory multiple myeloma, an incurable blood cancer. The trial is designed to investigate both single agent and combination activity of AT7519 with bortezomib (VelcadeĀ®).

Genetic diversity thwarts the usefulness of malaria vaccine

Researchers at the University of Maryland School of Medicine Center for Vaccine Development (CVD) have charted the extreme genetic differences that occur over time in the most dangerous malaria parasite in the world. While there is no approved vaccine for malaria, various experimental vaccines are in development.

Veeva OpenData services now available in Italy

Today, Veeva Systems announced that it has acquired Merqurio's healthcare professional (HCP) and healthcare organisation (HCO) database for Italy. With the acquisition of this market-leading Italian HCP and stakeholder data, Veeva OpenData now expands to a third major European market and builds on Veeva's commitment to deliver a new approach to customer reference data that is open, easy, and global.

Heilongjiang Tianlong Pharmaceutical changes R&D focus to antibiotics and cardiac drugs

China Sky One Medical, Inc., a leading fully integrated pharmaceutical company developing and producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that Heilongjiang Tianlong Pharmaceutical Company ("Tianlong"), the Company's wholly owned subsidiary, will change its R&D focus from external use medicines to antibiotics and cardiac drugs.

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dana R Sax is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dana R Sax, MD
275 W Macarthur Blvd,
Oakland, CA 94611-5641

Ph: (510) 752-1000
Dana R Sax, MD
275 W Macarthur Blvd,
Oakland, CA 94611-5641

Ph: (510) 752-1000

News Archive

Derek Muhs selected for Excellence in Branding and Marketing

Health Care Management China today announced that Co-Founder and Vice Chairman Derek Muhs has been nominated for Excellence in Branding and Marketing by the Awards Jury of the 6th Annual CMO ASIA AWARDS, to be held in Singapore on August 11, 2015.

Astex and MMRC commence Phase II clinical trial of AT7519 CDK inhibitor in multiple myeloma

Astex Therapeutics, the UK-based biotechnology company developing targeted therapies for oncology and virology, and the Multiple Myeloma Research Consortium announced today the initiation of a Phase II clinical trial of the cyclin-dependent kinase inhibitor, AT7519, to treat patients with relapsed or refractory multiple myeloma, an incurable blood cancer. The trial is designed to investigate both single agent and combination activity of AT7519 with bortezomib (VelcadeĀ®).

Genetic diversity thwarts the usefulness of malaria vaccine

Researchers at the University of Maryland School of Medicine Center for Vaccine Development (CVD) have charted the extreme genetic differences that occur over time in the most dangerous malaria parasite in the world. While there is no approved vaccine for malaria, various experimental vaccines are in development.

Veeva OpenData services now available in Italy

Today, Veeva Systems announced that it has acquired Merqurio's healthcare professional (HCP) and healthcare organisation (HCO) database for Italy. With the acquisition of this market-leading Italian HCP and stakeholder data, Veeva OpenData now expands to a third major European market and builds on Veeva's commitment to deliver a new approach to customer reference data that is open, easy, and global.

Heilongjiang Tianlong Pharmaceutical changes R&D focus to antibiotics and cardiac drugs

China Sky One Medical, Inc., a leading fully integrated pharmaceutical company developing and producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that Heilongjiang Tianlong Pharmaceutical Company ("Tianlong"), the Company's wholly owned subsidiary, will change its R&D focus from external use medicines to antibiotics and cardiac drugs.

Read more News

› Verified 2 days ago


Emergency Medicine Doctors in Oakland, CA

Daniel Mantuani, M.D.
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 1506 4th Ave Apt 5, Apt 5, Oakland, CA 94606
Phone: 504-390-5474    
Jennifer I. Harris, MD
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 275 W Macarthur, Oakland, CA 94611
Phone: 510-752-1000    
Benjamin J. Bonnes, MD
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 275 W Macarthur Blvd, Oakland, CA 94611
Phone: 510-752-1000    
Richard J. Knight, MD
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 275 W Macarthur Blvd, Oakland, CA 94611
Phone: 510-752-1000    
Michael S. Gelfond, MD
Emergency Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 275 W Macarthur, Oakland, CA 94611
Phone: 510-752-1000    
Dr. Kayla Enriquez, MD
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 1411 E 31st St, Oakland, CA 94602
Phone: 510-437-4564    
Dr. Emily Meilan Sze, M.D.
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 350 Hawthorne Ave, Oakland, CA 94609
Phone: 510-869-2500    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.